DIMDI closely collaborates with other institutes of the BMG in all areas, other federal and state authorities, as well as national and international public organisations:
The Association of the Scientific Medical Societies (AWMF) runs the electronic medicine journal, German Medical Science (gms), with publications from all medical fields of activity in cooperation with the German National Library of Medicine (ZB MED) and DIMDI.
The monthly Federal Health Gazette - Health Research - Health Protection covers all issues and areas with which the public health service and the state health policy deal with. DIMDI has been a member of the editorial advisory board for many years and participates in the topic discussion, makes its own contributions and coordinates main emphases concerning topics such as medical classifications, Health Technology Assessment (HTA), medical information systems and telematics in the health service.
The Federal Institute for Drugs and Medical Devices (BfArM) is involved in the authorisation of medicinal products and in the approval of clinical investigations/ performance evaluations of medical devices and in vitro diagnostic agents in Germany. DIMDI is the technical platform for the AMIS databases of the higher federal authorities for the authorisation of medicinal products and cooperates with them by forming a national drug information system according to § 67a AMG (PharmNet.Bund.de). Furthermore DIMDI is the technical platform for applications for approval of clinical investigations/ performance evaluations for medical devices and in vitro diagnostic agents and runs a database for those clinical investigations/ performance evaluations. BfArM also supplies DIMDI with data concerning incidents with medical devices in Germany. DIMDI informs the competent authorities of the Federal States about current incident reports and manages a database for them including all incidents.
DIMDI closely cooperates with the German Pharmaceutical Industry Association (BPI) in the drug information area.
The Federal Office of Consumer Protection and Food Safety (BVL) is involved in the authorisation of medical products in Germany. DIMDI is the technical platform for the AMIS databases of the higher federal authorities for the authorisation of medical products and cooperates with them by forming a national drug information system according to § 67a AMG.
DIMDI cooperates with the German Institute of Standardisation (DIN) on the NaMed sub-committee “Terminologies and semantic Networks”.
The cooperation between ZB MED - Information Centre of Life Science and DIMDI is tightly linked in many areas, as the electronic medicine journal, German Medical Science (gms).
DIMDI cooperates with the European Medicines Agency (EMA) in different telematics projects to convert the goals of the European Union Commission and is active in several groups.
DIMDI discusses within the National Board for Classification in Health Care current questions concerning medical classifications with health care representatives and cooperates with them on the further development of classifications.
Medical Service of the Central Organisation of statutory Health and Care Insurances (MDS) consults the Central Organisation of statutory Health and Care Insurances concerning health care and organizing public health. DIMDI is in contact with MDS concerning several themes, e. g. classifications and databases (AMIS for MDS).
DIMDI works together with the National Library of Medicine (NLM) as a MEDLARS-Center (Medical Literature Analysis and Retrieval System) and is represented in the International MEDLARS Center Policy Advisory Group (IMPAG).
DIMDI cooperates with the Paul-Ehrlich-Institut (PEI) as technical platform (see BfArM).
The ABDATA Pharma-Data-Service is the manufacturer of ABDA databases (ABDA proprietary medicinal products, ABDA interactions etc.)
The Pharmacovigilance and Advisory Centre for Embryonic Toxycology provides the database "Embryotox" with information on drug safety in pregnancy and lactation supported by the Federal Ministry of Health.
DIMDI advises the Federal Statistical Office on questions concerning cause of death coding and trains the signers of the statistical national office.
DIMDI's workings on the German-language version of the ICD-10 are carried out in close contact with the World Health Organization Centre. DIMDI continues to play a part in the maintenance of the English and French original versions of the WHO. DIMDI is "WHO Collaborating Centre for the Family of International Classifications" for German-speaking areas since 2003. DIMDI is represented in all work groups of the WHO cooperation centers. Furthermore, DIMDI is represented in the National Expert Group for the Harmonisation of the Indicator "Drug Related Death" and in the planning committee of the "International Collaborative Effort on Automating Cause of Death Statistics".
DIMDI cooperates with the Research Institute of the Local Health Care Funds (WIdO) on the production of the annually updated version of the official German ATC classification with defined daily doses.
DIMDI is part of the editorial advisory board of the German Journal for Evidence and Quality in Health Care. It participates in the topic discussion and makes its own contributions. DIMDI also communicates qualified contributions from experts from research and the health service.
DIMDI made a cooperation contract with the Central Research Institute of Ambulatory Health Care in Germany concerning the maintenance and further development of the international classification of diseases.
DIMDI cooperates with Central Authority of the Laender for Health Protection regarding Medicinal Products and Medical Devices (ZLG) in the scope of the information system on medical devices and by forming a national drug information system according to § 67a AMG.